QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel
Image created by Dr. Michael J. Miller QIAGEN N.V. headquartered in Venlo, Netherlands with a major …
Image created by Dr. Michael J. Miller QIAGEN N.V. headquartered in Venlo, Netherlands with a major …
Image created by Dr. Michael J. Miller Cepheid, a Danaher company, announced that it has received FD…
Image created by Dr. Michael J. Miller PhAST Corp., an in vitro diagnostics company building a singl…
Image created by Dr. Michael J. Miller Pattern Bioscience, an Austin, Texas-based developer of rapid…
Image created by Dr. Michael J. Miller The U.S. Food and Drug Administration (FDA) has granted 510(k…
Image created by Dr. Michael J. Miller WildTechDNA is bringing its ultra-rapid DNA detection technol…
Image created by Dr. Michael J. Miller Qiagen, N.V., a Netherlands-based holding company and is a gl…
Image created by Dr. Michael J. Miller The approach uses syndromic PCR to detect sexually transmitte…
Image created by Dr. Michael J. Miller Diasorin has received 510(k) clearance and CLIA waiver from t…
Image created by Dr. Michael J. Miller QIAGEN N.V. today highlighted its portfolio of molecular test…
Image created by Dr. Michael J. Miller Bruker Corporation announced the acquisition of the DISQVER® …
Image created by Dr. Michael J. Miller Sapphiros announced it has been awarded a multi-year project …
Image created by Dr. Michael J. Miller The research-use test was developed in six days to support su…
Image created by Dr. Michael J. Miller Roche has secured the CE Mark for its new Elecsys IGRA TB tes…
Image created by Dr. Michael J. Miller As public health officials work to contain the ongoing Bundib…
Image created by Dr. Michael J. Miller Seegene, a global molecular diagnostics company, announced th…
Image created by Dr. Michael J. Miller Waters Corporation has announced that the BD BACTEC™ FXI Cult…
Image created by Dr. Michael J. Miller The point-of-care assay provides results in 15 minutes and re…
Image created by Dr. Michael J. Miller bioMérieux, a biotechnology company specializing in in vitro …
Image created by Dr. Michael J. Miller Roche, through its subsidiary TIB MOLBIOL, has developed a Re…